United Current Assets vs Total Assets Per Share Analysis

UTHR Stock  USD 243.27  4.59  1.85%   
Trend analysis of United Therapeutics balance sheet accounts such as Total Assets of 7.5 B, Short Long Term Debt Total of 735 M, Other Current Liabilities of 116.3 M or Total Current Liabilities of 844.6 M provides information on United Therapeutics' total assets, liabilities, and equity, which is the actual value of United Therapeutics to its prevalent stockholders. By breaking down trends over time using United Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.

About United Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of United Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. United Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of United Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which United currently owns. An asset can also be divided into two categories, current and non-current.

United Therapeutics Balance Sheet Chart

United Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how United Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, United Therapeutics' Accounts Payable is relatively stable compared to the past year. As of 03/28/2024, Cash is likely to grow to about 1.3 B, while Non Currrent Assets Other are likely to drop slightly above 91.5 M.

Total Assets

Total assets refers to the total amount of United Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in United Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on United Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of United Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from United Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into United Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.As of 03/28/2024, Selling General Administrative is likely to drop to about 207.3 M. In addition to that, Discontinued Operations is likely to drop to 5,600
 2021 2022 2023 2024 (projected)
Gross Profit1.6B1.8B2.1B2.2B
Total Revenue1.7B1.9B2.3B2.4B

United Therapeutics fundamental ratios Correlations

0.840.240.641.00.97-0.140.97-0.220.850.990.330.920.740.240.560.89-0.30.890.990.920.460.950.990.830.48
0.840.270.370.80.80.260.8-0.250.610.860.20.90.430.130.820.77-0.30.920.80.840.40.820.790.820.51
0.240.27-0.240.220.23-0.180.330.020.330.210.540.420.440.080.510.29-0.550.270.260.230.390.140.190.40.09
0.640.37-0.240.630.69-0.310.57-0.190.610.630.230.360.690.45-0.090.560.020.580.620.480.420.530.650.470.24
1.00.80.220.630.96-0.190.98-0.220.860.980.330.90.740.20.510.88-0.310.850.990.910.420.950.990.810.47
0.970.80.230.690.96-0.180.94-0.150.850.960.430.860.790.40.530.84-0.310.90.960.920.610.880.960.820.55
-0.140.26-0.18-0.31-0.19-0.18-0.260.12-0.59-0.04-0.57-0.01-0.58-0.10.39-0.160.410.12-0.23-0.01-0.270.06-0.170.130.03
0.970.80.330.570.980.94-0.26-0.280.910.940.490.920.780.110.540.91-0.50.830.980.920.450.890.940.750.54
-0.22-0.250.02-0.19-0.22-0.150.12-0.28-0.3-0.19-0.14-0.3-0.210.41-0.11-0.330.34-0.2-0.26-0.130.06-0.2-0.20.020.05
0.850.610.330.610.860.85-0.590.91-0.30.790.630.770.860.20.350.8-0.560.690.890.740.540.680.830.570.41
0.990.860.210.630.980.96-0.040.94-0.190.790.270.90.690.260.580.84-0.250.910.950.920.440.930.970.860.49
0.330.20.540.230.330.43-0.570.49-0.140.630.270.370.660.070.210.42-0.860.310.380.440.650.120.260.140.57
0.920.90.420.360.90.86-0.010.92-0.30.770.90.370.610.110.790.88-0.440.90.910.890.450.890.880.760.44
0.740.430.440.690.740.79-0.580.78-0.210.860.690.660.610.390.210.73-0.480.630.770.590.640.540.740.560.26
0.240.130.080.450.20.4-0.10.110.410.20.260.070.110.390.120.080.360.390.220.130.70.160.310.4-0.07
0.560.820.51-0.090.510.530.390.54-0.110.350.580.210.790.210.120.53-0.320.750.530.620.430.580.50.60.35
0.890.770.290.560.880.84-0.160.91-0.330.80.840.420.880.730.080.53-0.460.810.920.80.40.860.860.650.39
-0.3-0.3-0.550.02-0.31-0.310.41-0.50.34-0.56-0.25-0.86-0.44-0.480.36-0.32-0.46-0.25-0.35-0.44-0.29-0.14-0.21-0.07-0.54
0.890.920.270.580.850.90.120.83-0.20.690.910.310.90.630.390.750.81-0.250.850.840.590.830.860.820.46
0.990.80.260.620.990.96-0.230.98-0.260.890.950.380.910.770.220.530.92-0.350.850.890.460.940.970.780.45
0.920.840.230.480.910.92-0.010.92-0.130.740.920.440.890.590.130.620.8-0.440.840.890.460.880.880.760.73
0.460.40.390.420.420.61-0.270.450.060.540.440.650.450.640.70.430.4-0.290.590.460.460.30.460.460.32
0.950.820.140.530.950.880.060.89-0.20.680.930.120.890.540.160.580.86-0.140.830.940.880.30.940.810.42
0.990.790.190.650.990.96-0.170.94-0.20.830.970.260.880.740.310.50.86-0.210.860.970.880.460.940.820.37
0.830.820.40.470.810.820.130.750.020.570.860.140.760.560.40.60.65-0.070.820.780.760.460.810.820.35
0.480.510.090.240.470.550.030.540.050.410.490.570.440.26-0.070.350.39-0.540.460.450.730.320.420.370.35
Click cells to compare fundamentals

United Therapeutics Account Relationship Matchups

United Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.9B4.6B5.2B6.0B7.2B7.5B
Other Current Liab39.6M319.2M301.6M339.1M71M116.3M
Total Current Liabilities463M323.3M305.4M343.2M804.4M844.6M
Total Stockholder Equity2.8B3.4B4.0B4.8B6.0B6.3B
Property Plant And Equipment Net738.5M731.6M780.9M861.5M1.0B1.1B
Net Debt111.6M61.3M(94.8M)(161.2M)(507.7M)(482.3M)
Retained Earnings3.3B3.8B4.3B5.0B6.0B6.3B
Accounts Payable23.1M9.9M4.1M3.8M5.6M10.2M
Cash738.4M738.7M894.8M961.2M1.2B1.3B
Non Current Assets Total2.0B2.4B2.8B2.7B3.6B3.8B
Non Currrent Assets Other154.6M169.9M108.2M114.3M151.8M91.5M
Cash And Short Term Investments2.3B3.0B3.6B4.2B3.0B3.1B
Net Receivables151.4M157.4M198.7M220.4M278.9M292.8M
Common Stock Shares Outstanding43.8M44.6M47.3M48.5M49.7M50.7M
Liabilities And Stockholders Equity3.9B4.6B5.2B6.0B7.2B7.5B
Non Current Liabilities Total670M896.5M904.8M904.6M377.8M269.4M
Other Current Assets133.8M88.3M100.4M219.2M166.2M174.5M
Other Stockholder Equity(531.3M)(430.5M)(333.8M)(190.8M)(30.2M)(28.7M)
Total Liab1.1B1.2B1.2B1.2B1.2B1.2B
Total Current Assets1.9B2.2B2.3B3.4B3.6B3.7B
Short Term Investments747.5M1.1B1.0B1.9B1.8B1.9B
Property Plant And Equipment Gross738.5M731M1.1B1.2B1.5B1.5B
Intangible Assets130.3M130.1M16.6M16.5M80.5M84.5M
Other Liab67M79.4M104.8M76.8M88.3M60.5M
Other Assets293.8M1.6B370.1M413.5M475.5M284.7M
Inventory93.4M86.5M93.8M102M111.8M55.9M
Property Plant Equipment738.5M731.6M780.9M861.5M990.7M1.0B
Net Tangible Assets2.6B3.2B3.9B4.8B5.5B5.7B
Retained Earnings Total Equity3.3B3.8B4.3B5.0B5.8B6.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether United Therapeutics is a strong investment it is important to analyze United Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact United Therapeutics' future performance. For an informed investment choice regarding United Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.
Note that the United Therapeutics information on this page should be used as a complementary analysis to other United Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for United Stock analysis

When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is United Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of United Therapeutics. If investors know United will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about United Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.626
Earnings Share
19.8
Revenue Per Share
49.733
Quarterly Revenue Growth
0.251
Return On Assets
0.1122
The market value of United Therapeutics is measured differently than its book value, which is the value of United that is recorded on the company's balance sheet. Investors also form their own opinion of United Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is United Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because United Therapeutics' market value can be influenced by many factors that don't directly affect United Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between United Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if United Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, United Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.